pocketful logo light
pocketful logo light
Orchid Pharma Ltd logo

Orchid Pharma Ltd

NSE: ORCHPHARMA BSE: 524372

₹988.20

(1.48%)

Sat, 19 Sept 2026, 02:37 pm

Orchid Pharma Share Price Live Chart

1 Day

(1.48%)

No Result Found

Summary

  • Market Cap (in Cr)

    4009.85

  • Net Profit (in Cr)

    95.76

  • P/B

    3.29

  • Sector P/E

    33.76

  • P/E

    39.54

  • EV/EBITDA

    27.13

  • Debt/Equity (Industry)

    0.24

  • Interest Cover (Industry)

    9.79

  • ROCE (Industry)

    14.04

  • RONW (Industry)

    13.17

  • ROE

    2.86

  • ROCE

    3.15

  • Debt/Equity

    0.13

  • EPS (TTM)

    5.35

  • Dividend Yield

    0

  • Book Value

    253.91

  • Interest Cover

    7.40

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters69.8469.8469.8469.8469.84
FII0.871.171.561.402.69
DII20.2519.3919.0419.4320.10
Public9.059.609.579.347.38
Government00000

Read More

Technical Analysis

RSI

51.25

MACD

-3.80

50 DMA

1000.91

200 DMA

790.85

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic1427.801218.501094.701009.20885.40799.90590.60
Fibonacci1218.501138.551089.151009.20929.25879.85799.90
Camarilla1028.461009.27990.091009.20951.71932.53913.34

Pivots Level: Classic

R3

+418.60

1427.80

R2

+209.30

1218.50

R1

+85.50

1094.70

1009.20
1009.20
Pivot Point
LTP: 989.70

S1

-123.80

885.40

S2

-209.30

799.90

S3

-418.60

590.60

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    978.74

  • 20-EMA

    981.29

  • 30-EMA

    982.81

  • 50-EMA

    971.73

  • 100-EMA

    915.83

  • 200-EMA

    858.06

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
25 May 2026board-meetingsAccounts, Quarterly Results
11 Feb 2026board-meetingsQuarterly Results
12 Aug 2025agm
29 May 2025egm
17 Jul 2024agm
08 Jul 2023agm
02 Jul 2023agmAnnual General Meeting03 Aug 2023
02 Dec 2022egm
22 Nov 2022egmExtra Ordinary General Meeting23 Dec 2022
22 Jun 2022agm

Read More

Peer Comparison

Orchid Pharma Ltd logo

Orchid Pharma Ltd

Cipla Ltd logo

Cipla Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Read More

Orchid Pharma Ltd About

Orchid Pharma 01 the leading ptlarrna<;eutlcal oompanies in India haad quartered In Channai and Involved in the davelopment, manufacture and marketing of diverse bulk aeWes. formulationS and nutraceu~cals with exports spanning over 40 counllies. Orcttid's world class manufacturing infrasl1uclure Include USFDA compliant API and Finished Dosage Form faciliUes at Chennai In India. OrctIid lias dediCilted stale-of-art and GLP compliant R&D infrastructure fOf Procen researetl, Drug Discovery and Pllarmaceut!cal researen at Chennal, India.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1992

Headquarters

CEO

R G Agarwal

Employees

Contact

Website icon

Website

http://www.orchidpharma.com

Email icon

Email

corporate@orchidpharma.com

Phone icon

Phone

91-44-28211000/28230000

Location icon

Location

Orchid Towers Nungambakkam, 313 Valluvar Kottam High Road, Chennai, Tamil Nadu, 600034

Read More

Orchid Pharma Ltd Company History

YearHistory
2015
  • The company received approval from the US FDA for the Abbreviated New Drug Application.
  • The company changed its name from Orchid Chemicals & Pharmaceuticals Ltd to Orchid Pharma Ltd.
  • The trading symbol of the company changed from ORCHIDCHEM to ORCHIDPHAR.
2016
  • Orchid received final USFDA approval for Rasagiline generic formulation.
2022
  • Orchid Pharma Limited launched a Qualified Institutional Placement programme of INR 500 Crore.
2023
  • Orchid Bio Pharma was granted approval by the Competent Authority under the Production Linked Incentive Scheme for manufacturing of product 7 ACA.
2024
  • The company Board of Directors informed about the Scheme of Amalgamation of Dhanuka Laboratories Limited with Orchid Pharma Limited under Regulation SEBI.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
UTI MUTUAL FUNDbulkBuy366507615.3730 May 2025
DHANUKA LABORATORIES LIMITEDbulkSell1300000571.2828 Nov 2023
UTI MUTUAL FUNDbulkBuy44500057128 Nov 2023
POLARIS BANYAN HOLDING PRIVATE LTDbulkBuy52900024.0210 Jan 2018
ADURJEE AND BROS PVT LTDbulkSell68488821.104 Jan 2018
SERUM INSTITUTE OF INDIA PRIVATE LIMITEDbulkSell131250020.103 Jan 2018
FORTUNE INTERCONTINENTAL PVT LTDbulkSell65811120.103 Jan 2018
FORTUNE INTERCONTINENTAL PVT LTDbulkSell47000020.303 Jan 2018
SERUM INSTITUTE OF INDIA PRIVATE LIMITEDbulkSell70565219.3719 Dec 2017
SERUM INSTITUTE OF INDIA PRIVATE LIMITEDbulkSell75000018.5518 Dec 2017

Read More

Orchid Pharma Ltd News

Orchid Pharma files FY26 BRSR report

Orchid Pharma Limited has submitted its Business Responsibility and Sustainability Report for FY26 to stock exchanges. The standalone report covers operations ending March 31, 2026, with pharma manufacturing accounting for 97% of turnover.

08 Sept 2026

companies

Orchid Pharma to allot shares in Dhanuka merger

Orchid Pharma Limited schedules board meeting on Aug 01, 2026, to approve equity share allotment to Dhanuka Laboratories shareholders under amalgamation scheme.

28 Jul 2026

companies

Orchid Pharma schedules Singapore investor roadshow

Orchid Pharma Ltd to hold physical investor roadshow in Singapore from July 29-31, 2026. WTD Mridul Dhanuka will lead discussions with no UPSI shared.

25 Jul 2026

companies

Orchid Pharma merger with Dhanuka Labs effective

Orchid Pharma's merger with Dhanuka Laboratories became effective on July 10, 2026. The NCLT order was filed with the Registrar of Companies.

10 Jul 2026

companies

Orchid Pharma signs Russia deal for Exblifep

Orchid Pharma entered a licensing pact with Pharmasyntez JSC for Exblifep in Russia. The deal offers a potential USD 178 million opportunity over 10 years.

07 Jul 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Orchid Pharma Ltd?

    As of 19/09/2026 at 8:07 PM, Orchid Pharma Ltd shares are trading at ₹988.20.

  • 2.What is the market cap. of Orchid Pharma Ltd?

    As of 19/09/2026, the market capitalization of Orchid Pharma Ltd is ₹5,091.44 crore.

  • 3.When was Orchid Pharma Ltd founded?

    Orchid Pharma Ltd was founded in 1992.

  • 4.What are the P/E and P/B ratios of Orchid Pharma Ltd?

    As of 19/09/2026, Orchid Pharma Ltd has a P/E ratio of 577.79 and a P/B ratio of 3.29.

  • 5.How can I buy shares of Orchid Pharma Ltd?

    You can buy shares of Orchid Pharma Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.What is the shareholding pattern of Orchid Pharma Ltd?

    As of March,2026, promoters hold 69.84% in Orchid Pharma Ltd, while FIIs, DIIs and public shareholders hold 0.87%, 20.25% and 9.05%, respectively.

  • 7.Does Orchid Pharma Ltd pay dividends?

    No, Orchid Pharma Ltd does not pay dividends to eligible shareholders currently.

  • 8.What are the latest financial results of Orchid Pharma Ltd?

    For January,2024, Orchid Pharma Ltd reported revenue of ₹919.00 crore and a net profit of ₹99.66 crore.

  • 9.What is the Stock symbol of Orchid Pharma Ltd?

    ORCHPHARMA is the stock symbol of Orchid Pharma Ltd.

  • 10.Who is the CEO of Orchid Pharma Ltd?

    The CEO of Orchid Pharma Ltd is R G Agarwal.

Open Your Free Demat Account

Enter your phone number